Prodrug based optimal drug delivery via membrane transporter/receptor
- 1 March 2001
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 1 (2) , 159-175
- https://doi.org/10.1517/14712598.1.2.159
Abstract
The carrier-mediated absorption of drugs and prodrugs across epithelial and endothelial barriers is emerging as a novel trend in biotherapeutics. This review examines the important advances in this field in the past decade. The feasibility of drug absorption of the parent drug or the appropriately modified prodrug via these transporters is discussed in detail. Several successful examples of synthesis of prodrugs recognised by the targeted transporters are described. The applicability of this approach in translocating drugs across the almost impenetrable blood-brain barrier (BBB) has also been examined.Keywords
This publication has 65 references indexed in Scilit:
- Cloning and Functional Characterization of a Sodium-Dependent Phosphate Transporter Expressed in Human Lung and Small IntestineBiochemical and Biophysical Research Communications, 1999
- Valacyclovir: A Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2Biochemical and Biophysical Research Communications, 1998
- Control of Growth Dynamics by Molecular Design in the MOCVD of Electronic CeramicsMRS Proceedings, 1997
- Bile acid transport systems as pharmaceutical targetsEuropean Journal of Clinical Investigation, 1996
- Vitamin B12 Mediated Oral Delivery Systems for Granulocyte-Colony Stimulating Factor and ErythropoietinBioconjugate Chemistry, 1995
- Bile acid derived HMG-CoA reductase inhibitorsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- Potocytosis: Sequestration and Transport of Small Molecules by CaveolaeScience, 1992
- Mechanisms of Intestinal Absorption of the Antibiotic, Fosfomycin, in Brush-Border Membrane Vesicles in Rabbits and Humans.Journal of Pharmacobio-Dynamics, 1992
- Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
- ProdrugsDrugs, 1985